Based on the existing evidence, SLC1A5 is an important target in the process of tumor cell progression, and new evidence shows that SLC1A5 inhibitors can provide considerable therapeutic effect for cancer treatment [26]. This evidence concerns the gene SLC1A5 and neoplasm.